THTX: Theratechnologies Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 63.91
Enterprise Value ($M) 87.79
Book Value ($M) -20.87
Book Value / Share -0.45
Price / Book -3.06
NCAV ($M) -35.34
NCAV / Share -0.77
Price / NCAV -1.81

Profitability (mra)
Return on Invested Capital (ROIC) -0.63
Return on Assets (ROA) -0.30
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 1.21
Current Ratio 1.34

Balance Sheet (mrq) ($M)
Current Assets 63.30
Assets 77.77
Liabilities 98.64
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 81.76
Operating Income -8.66
Net Income -23.96

Cash Flow Statement (mra) ($M)
Cash From Operations -5.68
Cash from Investing 1.11
Cash from Financing 14.78

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
02-14 13G Nantahala Capital Management, LLC 5.80
02-07 13G/A Hirschman Orin 8.10 -10.36
11-28 13D Soleus Capital Master Fund, L.P. 10.50
11-13 13D Investissement Quebec 19.90

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-03-27 7,265 51,474 14.11
2024-03-26 3,860 26,336 14.66
2024-03-25 3,649 8,931 40.86
2024-03-22 10,431 18,585 56.13

(click for more detail)

Similar Companies
TFFP – TFF Pharmaceuticals, Inc. TGTX – TG Therapeutics, Inc.
THAR – Tharimmune, Inc. TIL – Instil Bio, Inc.
TLSA – Tiziana Life Sciences Ltd


Financial data and stock pages provided by
Fintel.io